Exhibit 99.3
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
The accompanying unaudited pro forma condensed combined financial statements and explanatory notes presented below, which we refer to as the pro forma financial statements, have been prepared by Cowen Inc. (the “Company”) to reflect its completed acquisition of Convergex Group, Inc (“Convergex Group”), as described in Item 2.01 of the Current Report on Form 8-K filed on June 5, 2017.
The unaudited pro forma condensed combined financial statements and explanatory notes as of and for the year ended December 31, 2016, and the three months ended March 31, 2017, respectively, combine the historical consolidated financial condition and statements of operations of the Company with the historical consolidated statements of operations of Convergex Group for the year ended December 31, 2016 and for the three months ended March 31, 2017. The unaudited pro forma condensed combined balance sheet as of March 31, 2017 is presented as if the acquisition of Convergex had occurred on March 31, 2017. The unaudited pro forma condensed combined statement of operations for the three months ended March 31, 2017 and fiscal year ended December 31, 2016 is presented as if the acquisition of Convergex had occurred on January 1, 2016, the first day of the Company's 2016 fiscal year.
The unaudited pro forma condensed combined statements of operations have been prepared based on available information, using assumptions that the Company’s management believes are reasonable. The unaudited pro forma condensed combined statements of operations are provided for illustrative purposes only and are not necessarily indicative of the results of operations that would have been achieved had the transaction been consummated as of January 1, 2016, nor are they necessarily indicative of future results. The historical combined financial information has been adjusted to reflect factually supportable items that are directly attributable to the acquisition and, with respect to the statement of operations only, expected to have a continuing impact on combined results of operations. The unaudited pro forma condensed combined statements of operations do not reflect any operating efficiencies and associated cost savings that the Company may achieve with respect to the consolidated companies. The adjustments included in these pro forma financial statements are preliminary and may be revised.
The assumptions used and adjustments made in preparing the unaudited pro forma condensed combined statements of financial condition and statements of operations are described in the notes herein, and should be read in conjunction with the historical consolidated financial statements and accompanying notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s annual report on Form 10-K for the year ended December 31, 2016, and in the Company's quarterly report on Form 10-Q for the three months ended March 31, 2017 and March 31, 2016 as well as Convergex Group's historical audited financial statements and accompanying notes for the year ended December 31, 2016, included as Exhibit 99.1 in this Current Report on Form 8-K/A.
|
| | | | | | | | | | | | | | | |
Cowen Inc. Unaudited Pro Forma Condensed Combined Statements of Financial Condition (dollars in thousands, except share and per share data) As of March 31, 2017 |
| Cowen Inc. | | Convergex Group, LLC | | Pro Forma Adjustments | | Pro Forma Total |
Assets | | | | | | | |
Cash and cash equivalents | $ | 77,456 |
| | $ | 105,897 |
| | $ | (48,620 | ) | (a) | $ | 134,733 |
|
Cash collateral pledged | 14,696 |
| | — |
| | — |
| | 14,696 |
|
Segregated Cash | 1,503 |
| | 78,359 |
| | — |
| | 79,862 |
|
Securities owned, at fair value | 656,381 |
| | 3,384 |
| | — |
| | 659,765 |
|
Receivable on derivative contracts, at fair value | 18,137 |
| | — |
| | — |
| | 18,137 |
|
Securities borrowed | — |
| | 312,051 |
| | — |
| | 312,051 |
|
Other investments | 150,813 |
| | — |
| | — |
| | 150,813 |
|
Deposits with clearing organizations, brokers and banks | 12,987 |
| | 68,973 |
| | — |
| | 81,960 |
|
Receivable from brokers, dealers and clearing organizations | 150,635 |
| | 91,590 |
| | — |
| | 242,225 |
|
Receivable from customers | | | 32,106 |
| | | | 32,106 |
|
Fees receivable, net of allowance | 49,925 |
| | 35,661 |
| | — |
| | 85,586 |
|
Due from related parties | 42,792 |
| | — |
| | — |
| | 42,792 |
|
Fixed assets, net of accumulated depreciation | 40,836 |
| | 18,622 |
| | (17,297 | ) | (b) | 42,161 |
|
Goodwill | 60,678 |
| | — |
| | — |
| | 60,678 |
|
Intangible assets, net of accumulated amortization | 24,465 |
| | 2,358 |
| | 7,912 |
| (b) | 34,735 |
|
Deferred tax asset, net | 163,873 |
| | — |
| | 660 |
| (c) | 164,533 |
|
Other assets | 62,074 |
| | 8,898 |
| | (775 | ) | (d) | 70,197 |
|
Consolidated Funds | | | | | | |
|
|
Cash and cash equivalents | 10,293 |
| | — |
| | — |
| | 10,293 |
|
Securities owned, at fair value | 91,759 |
| | — |
| | — |
| | 91,759 |
|
Receivable on derivative contracts, at fair value | 909 |
| | — |
| | — |
| | 909 |
|
Other investments | 401,528 |
| | — |
| | — |
| | 401,528 |
|
Receivable from brokers | 9,289 |
| | — |
| | — |
| | 9,289 |
|
Other assets | 518 |
| | — |
| | | | 518 |
|
Total Assets | $ | 2,041,547 |
| | $ | 757,899 |
| | $ | (58,120 | ) | | $ | 2,741,326 |
|
Liabilities and Stockholders' Equity | | | | | | | |
Securities sold, not yet purchased, at fair value | 335,676 |
| | — |
| | — |
| | 335,676 |
|
Payable for derivative contracts, at fair value | 14,143 |
| | — |
| | — |
| | 14,143 |
|
Securities Loaned | — |
| | 360,204 |
| | — |
| | 360,204 |
|
Payables to brokers, dealers and clearing organizations | 124,451 |
| | 84,217 |
| | — |
| | 208,668 |
|
Payable to customers | 70,479 |
| | 19,155 |
| | — |
| | 89,634 |
|
Commission management payable | 4,819 |
| | 88,738 |
| | — |
| | 93,557 |
|
Compensation payable | 31,794 |
| | 21,463 |
| | 12,833 |
| (e) | 66,090 |
|
Notes payable and other debt | 77,890 |
| | 976 |
| | — |
| | 78,866 |
|
Convertible debt | 132,055 |
| | — |
| | — |
| | 132,055 |
|
Fees payable | 7,876 |
| | 128 |
| | — |
| | 8,004 |
|
Due to related parties | 573 |
| | — |
| | — |
| | 573 |
|
Accounts payable, accrued expenses | 62,014 |
| | 33,551 |
| | 3,179 |
| (f) | 98,744 |
|
| | | | | (944 | ) | (g) | (944 | ) |
Consolidated Funds | | | | | | |
|
|
Payable for derivative contracts, at fair value | 876 |
| | — |
| | — |
| | 876 |
|
Payable to brokers | 1,652 |
| | — |
| | — |
| | 1,652 |
|
Contributions received in advance | 50 |
| | — |
| | — |
| | 50 |
|
Capital withdrawals payable | 4,368 |
| | — |
| | — |
| | 4,368 |
|
Accounts payable, accrued expenses and other liabilities | 441 |
| | — |
| | — |
| | 441 |
|
Total Liabilities | 869,157 |
| | 608,432 |
| | 15,068 |
| | 1,492,657 |
|
|
| | | | | | | | | | | | | | | |
Cowen Inc. Unaudited Pro Forma Condensed Combined Statements of Financial Condition (dollars in thousands, except share and per share data) As of March 31, 2017 |
(Continued) | | | | | | | |
| Cowen Inc. | | Convergex Group, LLC | | Pro Forma Adjustments | | Pro Forma Total |
| | | | | | | |
Commitments and Contingencies | | | | | | | |
Redeemable non-controlling interests | 394,132 |
| | — |
| | — |
| | 394,132 |
|
| | | | | | | |
Preferred stock, par value $0.01 per share: 10,000,000 shares authorized, 120,750 shares issued and outstanding as of March 31, 2017 (aggregate liquidation preference of $120,750,000) and 120,750 shares issued and outstanding as of as of December 31, 2016 (aggregate liquidation preference of $120,750,000), respectively | 1 |
| | — |
| | — |
| | 1 |
|
Class A common stock, par value $0.01 per share: 62,500,000 shares authorized, 37,451,533 shares issued and 27,312,493 outstanding as of March 31, 2017 and 36,542,091 shares issued and 26,731,289 outstanding as of December 31, 2016, respectively (including 162,176 and 162,176 restricted shares, respectively) | 292 |
| | — |
| | 32 |
| (h) | 324 |
|
Class B common stock, par value $0.01 per share: 62,500,000 authorized, no shares issued and outstanding | — |
| | — |
| | — |
| | — |
|
Additional paid-in capital | 937,425 |
| | | | 76,247 |
| (h) | 1,013,672 |
|
(Accumulated deficit) retained earnings | (1,156 | ) | | 149,467 |
| | (149,467 | ) | (h) | (1,156 | ) |
Accumulated other comprehensive income (loss) | (4 | ) | | — |
| | — |
| | (4 | ) |
Less: Class A common stock held in treasury, at cost, 10,593,191 and 9,810,802 shares, respectively | (158,300 | ) | | — |
| | — |
| | (158,300 | ) |
Total Stockholders' Equity | 778,258 |
| | 149,467 |
| | (73,188 | ) | | 854,537 |
|
Total Liabilities and Stockholders' Equity | $ | 2,041,547 |
| | $ | 757,899 |
| | $ | (58,120 | ) | | $ | 2,741,326 |
|
| | | | | | | |
Common shares outstanding | 27,312,493 |
| | | | 3,162,278 |
| | 30,474,771 |
|
The accompanying notes are an integral part of these unaudited pro forma condensed combined financial statements.
|
| | | | | | | | | | | | | | | | |
Cowen Inc. Unaudited Pro Forma Condensed Combined Statements of Operations (dollars in thousands, except per share data) For the three months ended March 31, 2017 | |
| Cowen Inc. | | Convergex Group, LLC | | Pro Forma Adjustments | | Pro Forma Total | |
Revenues | | | | | | | | |
Investment banking | $ | 36,553 |
| | $ | — |
| | $ | — |
| | $ | 36,553 |
| |
Brokerage | 50,534 |
| | 42,073 |
| | — |
| | 92,607 |
| |
Management fees | 8,708 |
| | — |
| | — |
| | 8,708 |
| |
Incentive income | 546 |
| | — |
| | — |
| | 546 |
| |
Interest and dividends | 5,089 |
| | 4,378 |
| | — |
| | 9,467 |
| |
Reimbursement from affiliates | 1,652 |
| | — |
| | — |
| | 1,652 |
| |
Aircraft lease revenue | 1,059 |
| | — |
| | — |
| | 1,059 |
| |
Reinsurance premiums | 7,089 |
| | — |
| | — |
| | 7,089 |
| |
Other revenues | 1,400 |
| | 1,352 |
| | — |
| | 2,752 |
| |
Consolidated Funds | | | | | — |
| |
| |
Interest and dividends | 1,994 |
| | — |
| | — |
| | 1,994 |
| |
Other revenues | 347 |
| | — |
| | — |
| | 347 |
| |
Total revenues | 114,971 |
| | 47,803 |
| | — |
| | 162,774 |
| |
Expenses | | | | | | | | |
Employee compensation and benefits | 76,673 |
| | 27,942 |
| | (655 | ) | (i) | 103,960 |
| |
Floor brokerage and trade execution | 8,323 |
| | 12,883 |
| | — |
| | 21,206 |
| |
Interest and dividends | 9,930 |
| | 2,133 |
| | — |
| | 12,063 |
| |
Professional, advisory and other fees | 5,816 |
| | 954 |
| | (600 | ) | (j) | 6,170 |
| |
Service fees | 2,616 |
| | — |
| | — |
| | 2,616 |
| |
Communications | 4,760 |
| | 10,622 |
| | — |
| | 15,382 |
| |
Occupancy and equipment | 7,063 |
| | 2,099 |
| | (71 | ) | (k) | 9,091 |
| |
Depreciation and amortization | 3,028 |
| | 2,792 |
| | (2,379 | ) | (l) | 3,441 |
| |
Client services and business development | 7,762 |
| | 779 |
| | — |
| | 8,541 |
| |
Reinsurance claims, commissions and amortization of deferred acquisition costs | 6,178 |
| | — |
| | — |
| | 6,178 |
| |
Restructuring costs | — |
| | 87 |
| | — |
| | 87 |
| |
Other expenses | 3,261 |
| | 273 |
| | | | 3,534 |
| |
Consolidated Funds | | | | | | |
| |
Interest and dividends | 3,983 |
| | — |
| | — |
| | 3,983 |
| |
Professional, advisory and other fees | 392 |
| | — |
| | — |
| | 392 |
| |
Floor brokerage and trade execution | 109 |
| | — |
| | — |
| | 109 |
| |
Other expenses | 479 |
| | — |
| | — |
| | 479 |
| |
Total expenses | 140,373 |
| | 60,564 |
| | (3,705 | ) | | 197,232 |
| |
Other income (loss) | | | | | | | | |
Net gains (losses) on securities, derivatives and other investments | 26,056 |
| | — |
| | — |
| | 26,056 |
| |
Consolidated Funds | | | | | | | | |
Net realized and unrealized gains (losses) on investments and other transactions | 9,578 |
| | — |
| | — |
| | 9,578 |
| |
Net realized and unrealized gains (losses) on derivatives | 3,865 |
| | — |
| | — |
| | 3,865 |
| |
Net gains (losses) on foreign currency transactions | (97 | ) | | — |
| | — |
| | (97 | ) | |
Total other income (loss) | 39,402 |
| | — |
| | — |
| | 39,402 |
| |
Income (loss) before income taxes | 14,000 |
| | (12,761 | ) | | 3,705 |
| | 4,944 |
| |
Income tax expense (benefit) | 1,911 |
| | 13 |
| | 116 |
| (m) | 2,040 |
| |
|
| | | | | | | | | | | | | | | | |
Cowen Inc. Unaudited Pro Forma Condensed Combined Statements of Operations (dollars in thousands, except per share data) For the three months ended March 31, 2017 | |
(Continued) | | | | | | | | |
| Cowen Inc. | | Convergex Group, LLC | | Pro Forma Adjustments | | Pro Forma Total | |
Net income (loss) | 12,089 |
| | (12,774 | ) | | 3,589 |
| | 2,904 |
| |
Net income (loss) attributable to redeemable non-controlling interests in consolidated subsidiaries and funds | 9,105 |
| | — |
| | — |
| | 9,105 |
| |
Net income (loss) attributable to Cowen Inc. | 2,984 |
| | (12,774 | ) | | 3,589 |
| | (6,201 | ) | |
Preferred stock dividends | 1,698 |
| | — |
| | — |
| | 1,698 |
| |
Net income (loss) attributable to Cowen Inc. common stockholders | $ | 1,286 |
| | $ | (12,774 | ) | | $ | 3,589 |
| | $ | (7,899 | ) | |
Weighted average common shares outstanding: | |
| | |
| | | | |
| |
Basic | 27,061 |
| | | | 3,127 |
| | 30,188 |
| (n) |
Diluted | 28,401 |
| | | | 1,787 |
| | 30,188 |
| (n) |
Earnings (loss) per share: | | | | | | | | |
Basic | $ | 0.05 |
| |
|
| |
| | $ | (0.26 | ) | |
Diluted | $ | 0.05 |
| |
|
| |
| | $ | (0.26 | ) | |
The accompanying notes are an integral part of these unaudited pro forma condensed combined financial statements.
|
| | | | | | | | | | | | | | | | |
Cowen Inc. Unaudited Pro Forma Condensed Combined Statements of Operations (dollars in thousands, except per share data) For the twelve months ended December 31, 2016 | |
| Cowen Inc. | | Convergex Group, LLC | | Pro Forma Adjustments | | Pro Forma Total | |
Revenues | | | | | | | | |
Investment banking | $ | 133,279 |
| | $ | — |
| | $ | — |
| | $ | 133,279 |
| |
Brokerage | 199,180 |
| | 187,794 |
| | — |
| | 386,974 |
| |
Management fees | 40,612 |
| | — |
| | — |
| | 40,612 |
| |
Incentive income | 8,334 |
| | — |
| | — |
| | 8,334 |
| |
Interest and dividends | 14,732 |
| | 14,467 |
| | — |
| | 29,199 |
| |
Reimbursement from affiliates | 10,504 |
| | — |
| | — |
| | 10,504 |
| |
Aircraft lease revenue | 4,161 |
| | — |
| | — |
| | 4,161 |
| |
Reinsurance premiums | 32,459 |
| | — |
| | — |
| | 32,459 |
| |
Other revenues | 22,355 |
| | 7,829 |
| | — |
| | 30,184 |
| |
Consolidated Funds | | | — |
| | — |
| | | |
Interest and dividends | 4,792 |
| | — |
| | — |
| | 4,792 |
| |
Other revenues | 1,157 |
| | — |
| | — |
| | 1,157 |
| |
Total revenues | 471,565 |
| | 210,090 |
| | — |
| | 681,655 |
| |
Expenses | | | | | | | | |
Employee compensation and benefits | 310,038 |
| | 99,664 |
| | (6,159 | ) | (i) | 403,543 |
| |
Floor brokerage and trade execution | 32,286 |
| | 58,872 |
| | — |
| | 91,158 |
| |
Interest and dividends | 29,308 |
| | 7,109 |
| | — |
| | 36,417 |
| |
Professional, advisory and other fees | 23,190 |
| | 4,106 |
| | — |
| | 27,296 |
| |
Service fees | 7,918 |
| | — |
| | — |
| | 7,918 |
| |
Communications | 17,768 |
| | 40,299 |
| | — |
| | 58,067 |
| |
Occupancy and equipment | 32,286 |
| | 8,528 |
| | (531 | ) | (k) | 40,283 |
| |
Depreciation and amortization | 12,713 |
| | 12,183 |
| | (9,834 | ) | (l) | 15,062 |
| |
Client services and business development | 27,828 |
| | 3,071 |
| | — |
| | 30,899 |
| |
Reinsurance claims, commissions and amortization of deferred acquisition costs | 29,904 |
| | — |
| | — |
| | 29,904 |
| |
Restructuring costs | — |
| | 1,507 |
| | — |
| | 1,507 |
| |
Other expenses | 14,815 |
| | 16,055 |
| | | | 30,870 |
| |
Consolidated Funds | | | | | | | | |
Interest and dividends | 6,434 |
| | — |
| | — |
| | 6,434 |
| |
Professional, advisory and other fees | 1,148 |
| | — |
| | — |
| | 1,148 |
| |
Floor brokerage and trade execution | 431 |
| | — |
| | — |
| | 431 |
| |
Other expenses | 1,051 |
| | — |
| | — |
| | 1,051 |
| |
Total expenses | 547,118 |
| | 251,394 |
| | (16,524 | ) | | 781,988 |
| |
Other income (loss) | | | | | | | | |
Net gains (losses) on securities, derivatives and other investments | 23,381 |
| | — |
| | — |
| | 23,381 |
| |
Consolidated Funds | | | | | | | | |
Net realized and unrealized gains (losses) on investments and other transactions | 7,085 |
| | — |
| | — |
| | 7,085 |
| |
Net realized and unrealized gains (losses) on derivatives | 13,503 |
| | — |
| | — |
| | 13,503 |
| |
Net gains (losses) on foreign currency transactions | 97 |
| | — |
| | — |
| | 97 |
| |
Total other income (loss) | 44,066 |
| | — |
| | — |
| | 44,066 |
| |
Income (loss) before income taxes | (31,487 | ) | | (41,304 | ) | | 16,524 |
| | (56,267 | ) | |
Income tax expense (benefit) | (19,092 | ) | | 442 |
| | (776 | ) | (m) | (19,426 | ) | |
|
| | | | | | | | | | | | | | | | |
Cowen Inc. Unaudited Pro Forma Condensed Combined Statements of Operations (dollars in thousands, except per share data) For the twelve months ended December 31, 2016 | |
(Continued) | | | | | | | | |
| Cowen Inc. | | Convergex Group, LLC | | Pro Forma Adjustments | | Pro Forma Total | |
Net income (loss) | (12,395 | ) | | (41,746 | ) | | 17,300 |
| | (36,841 | ) | |
Net income (loss) attributable to redeemable non-controlling interests in consolidated subsidiaries and funds | 6,882 |
| | — |
| | — |
| | 6,882 |
| |
Net income (loss) attributable to Cowen Inc. | (19,277 | ) | | (41,746 | ) | | 17,300 |
| | (43,723 | ) | |
Preferred stock dividends | 6,792 |
| | — |
| | — |
| | 6,792 |
| |
Net income (loss) attributable to Cowen Inc. common stockholders | $ | (26,069 | ) | | $ | (41,746 | ) | | $ | 17,300 |
| | $ | (50,515 | ) | |
Weighted average common shares outstanding: | |
| | |
| | | | |
| |
Basic | 26,857 |
| | | | 3,154 |
| | 30,011 |
| (n) |
Diluted | 26,857 |
| | | | 3,154 |
| | 30,011 |
| (n) |
Earnings (loss) per share: | | | | | | | | |
Basic | $ | (0.97 | ) | | | | | | $ | (1.68 | ) | |
Diluted | $ | (0.97 | ) | | | | | | $ | (1.68 | ) | |
The accompanying notes are an integral part of these unaudited pro forma condensed combined financial statements.
Cowen Inc.
Notes to Unaudited Condensed Combined Financial Statements
1. Description of the acquisition
On April 2, 2017, the Company, through its wholly owned subsidiary Cowen CV Acquisition LLC, entered into a securities purchase agreement with, among others, Convergex Holdings LLC to acquire all the outstanding interests in Convergex Group, LLC ("Convergex Group") (subsequently renamed to Cowen Execution Holdco LLC), a provider of agency based execution services and trading technology to middle market institutional investors and broker-dealers. Convergex Group's operations were primarily conducted through two U.S. Securities Exchange Commission ("SEC") registered broker-dealers, Convergex Execution Services LLC (subsequently renamed to Cowen Execution Services LLC) ("Cowen Execution") and Westminster Research Associates LLC ("Westminster Research") and also Convergex Limited (subsequently renamed to Cowen Execution Services Limited) ("Cowen Execution Ltd"), which is based in the United Kingdom and regulated by the Financial Conduct Authority ("FCA"). The purchase price was paid approximately 50% in cash and 50% in Cowen Inc. Class A common stock. We refer to the acquisition Convergex Group as the "Acquisition."
The acquisition was consummated effective as of June 1, 2017. The adjusted aggregate estimated purchase price was $96.2 million, which was determined based on closing date tangible book value of Convergex Group, less certain closing adjustments. A portion of the preliminary purchase price was deposited into escrow as a reserve for any future claims against the sellers of Convergex Group. On closing, the Company paid cash of $48.6 million and issued 3,162,278 of the Company’s Class A common stock determined based on the 30-day volume-weighted average price per share of $15.05 as of May 30, 2017.
2. Basis of Presentation
The unaudited pro forma condensed combined financial statements were prepared using the acquisition method of accounting in accordance with generally accepted accounting principles in the United States ("GAAP") and were derived based on the historical financial statements of the Company and the financial statements of Convergex Group after giving effect to the Acquisition and after applying the reclassifications and adjustments described in the accompanying notes to the unaudited pro forma condensed combined financial statements. The unaudited pro forma condensed combined balance sheet as of March 31, 2017 is presented as if the acquisition of Convergex had occurred on March 31, 2017. The unaudited pro forma condensed combined statement of operations for the three months ended March 31, 2017 and fiscal year ended December 31, 2016 is presented as if the acquisition of Convergex had occurred on January 1, 2016, the first day of the Company's 2016 fiscal year.
The unaudited pro forma condensed combined financial statements are presented for information purposes only and are not intended to reflect the results of operations or financial position of the combined company that would have resulted had the Acquisition been effective during the period presented or the results that may be obtained by the combined company in the future. Additionally, the unaudited pro forma condensed combined financial statements should be read in conjunction with the historical audited consolidated financial statements and accompanying notes of the Company included in the Annual Report on Form 10-K for the year ended December 31, 2016 as well as Convergex Group's historical audited financial statements and accompanying notes for the year ended December 31, 2016, included as Exhibit 99.1 in this Current Report on Form 8-K/A.
3. Net Assets Acquired
The Company is currently in the process of finalizing its purchase price allocation of Convergex Group; therefore, the purchase price adjustments and allocation of the purchase price to the net assets acquired, as filed in our Quarterly Report on Form 10-Q for the period ended June 30, 2017, are preliminary and subject to measurement period adjustments and will be finalized as necessary, up to one year after the acquisition's closing date, as the information becomes available. The adjusted aggregate estimated purchase price was $96.2 million, which was determined based on closing date tangible book value of Convergex Group, less certain closing adjustments. A portion of the preliminary purchase price was deposited into escrow as a reserve for any future claims against the sellers of Convergex Group. On closing, the Company paid cash of $48.6 million and issued 3,162,278 of the Company’s Class A common stock determined based on the 30-day volume-weighted average price per share of $15.05 as of May 30, 2017.
4. Pro Forma Adjustments and Assumptions
The following is a summary of pro forma adjustments reflected in the Unaudited Pro Forma Condensed Combined Statements of Financial Condition as of March 31, 2017:
(a) Reflects the portion of the purchase price paid in cash.
(b) Reflects the estimated fair value of Convergex Group's fixed assets and intangible assets. Convergex Group's fixed assets and intangibles assets, which had a net books value of $18.6 million and $2.4 million, respectively, on the date of the acquisition were adjusted to reflect a fair value of $1.3 million and $10.3 million, respectively.
(c) Represents the tax impact of the Pro Forma Adjustments which was primarily offset by a valuation allowance adjustment that was determined based on Cowen's and Convergex Group's historical valuation allowance positions.
(d) Reflects an adjustment to the fair value of software.
(e) Represents adjustments for change of control, acceleration of vested deferred compensation awards, pre-acquisition severance, and other compensation issued to certain Convergex Group employees.
(f) Represents the impact of an unfavorable lease liability related to certain of Convergex Group's real estate leases that were at higher than market rates at the closing date, partially offset by the removal of Convergex Groups deferred rent balances on the date of the acquisition.
(g) Reflects an accrual for certain pre-acquisition discontinued contracts and an elimination of an amount due to sellers.
(h) Reflects the issuance of the par value of common stock issued during the acquisition and the elimination of historical retained earnings of Convergex Group.
The following is a summary of pro forma adjustments reflected in the Unaudited Pro Forma Condensed Combined Statements of Operations for the three month period ended March 31, 2017 and the twelve month period ended December 31, 2016:
(i) Reflects an acceleration of vested deferred compensation expense, pre-acquisition severance, and other compensation issued to certain Convergex Group employees.
(j) Represents the elimination of nonrecurring charges included in the Company's historical results of operations which resulted directly from the acquisition. These amounts primarily related to legal and other professional fees.
(k) Reflects the adjustment to amortization, over the remaining lease term of 25 months using the straight line method, of the fair value of lease obligation related to Convergex Group's real estate leases that were at higher than market rates at the closing date.
(l) Reflects the reduction in depreciation and amortization expense, using the straight line method, related to the fair value of fixed and intangible assets recognized in connection with the acquisition. The estimated useful lives of the fixed assets range from 2 to 5 years. The estimated useful lives of the intangible assets range from 6 months to 9 years.
(m) Represents the tax impact of the Pro Forma Adjustments which was primarily offset by a valuation allowance adjustment that was determined based on Cowen's and Convergex Group's historical valuation allowance positions.
(n) As the unaudited pro forma condensed combined statements of operations assume that the acquisition occurred as of the beginning of the period presented, all 3,162,278 shares of Cowen Class A common stock that were issued to the sellers of Convergex Group are assumed to be outstanding for the entire period for the unaudited pro forma net loss per share calculation of the combined company. An adjustment has been made to the weighted average shares outstanding since, due to the pro forma combined losses, the outstanding restricted stock and stock options would be anti-dilutive.